Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 65, Issue 4, Pages -Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01445-20
Keywords
Mycobacterium; Mycobacterium tuberculosis; animal models; antimicrobial activity; antimicrobial agents; enzyme activation
Categories
Funding
- Netherlands Organization for Scientific Research (NWO) [TTW-NACTAR-16445]
- VENI grant [016.Veni.171.090]
- Amsterdam Infection and Immunity (AIII)
Ask authors/readers for more resources
Screening for antituberculosis compounds using Mycobacterium tuberculosis is costly and time-consuming due to the requirement of biosafety level 3 facilities. Mycobacterium marinum, a close genetic relative, shows promise as a model for drug screening, with genetic differences in drug susceptibility compared to M. tuberculosis. By overexpressing drug activators EthA and KatG, M. marinum strains demonstrated increased susceptibility to key antituberculosis drugs and potential novel compounds from the TB Alliance library, making them valuable tools for drug discovery.
Screening strategies for antituberculosis compounds using Mycobacterium tuberculosis are time consuming and require biosafety level 3 (BSL3) facilities, which makes the development of high-throughput assays difficult and expensive. Mycobacterium marinum, a close genetic relative of M. tuberculosis, possesses several advantages as a suitable model for tuberculosis drug screening. However, despite the high genetic similarity, there are some obvious differences in susceptibility to some tuberculosis drugs between these two species, especially for the prodrugs ethionamide and isoniazid. In this study, we aimed to improve M. marinum as a model for antituberculosis drug identification by heterologous expression of two common drug activators, EthA and KatG. These two activators were overexpressed in M. marinum, and the strains were tested against ethionamide, isoniazid, and a library of established antimycobacterial compounds from TB Alliance to compare drug susceptibility. Both in vitro and in vivo using zebrafish larvae, these genetically modified M. marinum strains showed significantly higher susceptibility against ethionamide and isoniazid, which require activation by EthA and KatG. More importantly, a strain overexpressing both ethA and katG was potentially more susceptible to approximately 20% of the antituberculosis hit compounds from the TB Alliance library. Most of these compounds were activated by EthA in M. marinum. Four of these compounds were selected for further analysis, and three of them showed obvious EthA-dependent activity against M. tuberculosis. Overall, our developed M. marinum strains are valuable tools for high-throughput discovery of potential novel antituberculosis prodrugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available